Back to CVE records
Medium 4.3HealthcarePublished Jun 29, 2020
CVE-2019-18246BIOTRONIK CardioMessenger II, The affected products do not properly enforce mutual authentication with the BIOTRONIK Remote Communication infrastructure.
Updated under an hour ago ()
Does this affect you?
It affects biotronik cardiomessenger_ii-s_gsm_firmware and 1 other product. Add what you run to find out whether that includes you.
EPSS puts the chance of exploitation in the next 30 days at 0.48%, higher than 40% of scored CVEs.
Do this next
Start free and add your stack
Free account, 1 product
BIOTRONIK CardioMessenger II, The affected products do not properly enforce mutual authentication with the BIOTRONIK Remote Communication infrastructure.
- CVSS
- 4.3 MEDIUM (v3.1, NVD)CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N
- Weakness (CWE)
- CWE-287
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- 0.48% (percentile 40)
- Assigned by
- icscert
- NVD analysis
- Modified
- Record last updated
- Aug 5, 2024
- First seen by InfoSec Signals
- Oct 12, 2026
Affected products
biotronik cardiomessenger_ii-s_gsm_firmware biotronik:cardiomessenger_ii-s_gsm_firmware | 2.20 | NVD |
biotronik cardiomessenger_ii-s_t-line_firmware biotronik:cardiomessenger_ii-s_t-line_firmware | 2.20 | NVD |
References
- https://www.us-cert.gov/ics/advisories/icsma-20-170-05x-refsource-misc, third-party-advisory, us-government-resource
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.